Skip to content

Ozempic and GLP-1 Drugs: How They Actually Work

A doctor explains GLP-1 drugs like Ozempic and Wegovy: how they work, real results and side effects, what happens when you stop, and who they suit.

Check your own numbers

See a doctor promptly if

  • Severe stomach or upper back pain that will not settle, with or without vomiting
  • Vomiting that stops you keeping fluids down for more than a day
  • Sudden pain under the right ribs with fever, yellow eyes, or pale stools
  • New or worsening thoughts of self harm while taking any weight medicine
  • Sudden change in vision, or new numbness and tingling in the feet
  • Using a compounded or online product and feeling faint, shaky, sweaty, or confused

The short version

  • GLP-1 drugs copy a gut hormone. They slow the stomach and quiet appetite signals in the brain.
  • In trials, average loss was near 15 percent of body weight with semaglutide. Tirzepatide averaged over 20 percent.
  • Nausea and constipation are common early and usually fade. Weight returns for most people after stopping.
  • Muscle is lost along with fat. Protein at every meal and strength training protect it.
Ozempic and GLP-1 Drugs: How They Actually Work

For the first time, medicine has drugs that reliably produce major weight loss. That sentence deserves its fine print too. Here is the mechanism, the numbers, the costs, and the parts the ads leave out.

The mechanism, in plain words#

After you eat, the gut releases a hormone called GLP-1. It does three things at once.

It tells the pancreas to release insulin when blood sugar rises. It slows the stomach, so fullness lasts. And it speaks to appetite centers in the brain, lowering the drive to eat again soon.

Your own GLP-1 breaks down within minutes. The drugs are long acting copies, built to last for days. Most are injected under the skin weekly.

The effect people describe is not willpower. It is quiet. The constant background negotiation with food, what many people call food noise, largely stops.

Tirzepatide adds a second gut signal called GIP, which likely explains its larger average results.

What the trials actually showed#

Numbers matter here, because marketing rounds them up and critics round them down.

In the main semaglutide weight trial, adults with overweight or obesity lost an average of about 15 percent of body weight. That trial ran 68 weeks, roughly 16 months. The placebo group lost about 2.4 percent. For an adult of 220 pounds (100 kg), 15 percent is about 33 pounds (15 kg).

In the main tirzepatide trial, average loss at the highest dose passed 20 percent over 72 weeks. Nothing prescribable before this class came close.

Averages hide a wide spread. Around one in ten lost very little. Others lost more than a third of their body weight. No test predicts which group you land in.

Weight is not the only outcome. In adults with existing heart disease and overweight, semaglutide lowered heart attacks, strokes and heart related deaths by about 20 percent. That is why cardiologists now discuss a weight drug at all. Blood sugar, blood pressure and sleep apnea severity improved too.

The medicines in the class, and how they differ#

They are not interchangeable, and the same molecule is often sold under two names for two purposes.

MedicineWhat it copiesHow it is givenApproved use
Semaglutide (Ozempic, Rybelsus)GLP-1Weekly shot, or daily tabletType 2 diabetes, and heart risk in some groups
Semaglutide (Wegovy)GLP-1Weekly shotWeight management, and heart risk in some groups
Tirzepatide (Mounjaro)GLP-1 and GIPWeekly shotType 2 diabetes
Tirzepatide (Zepbound)GLP-1 and GIPWeekly shotWeight management, and sleep apnea in some adults
Liraglutide (Victoza, Saxenda)GLP-1Daily shotType 2 diabetes, or weight management
Dulaglutide (Trulicity)GLP-1Weekly shotType 2 diabetes

Choosing between them belongs to you and your own doctor. It turns on your other conditions, what you tolerate, what is available, and what you can afford.

Who they are approved for#

Approval is narrower than the conversation online suggests. For weight management, regulators generally set the bar at a BMI of 30 or above, or 27 or above with a weight related condition. Those conditions include high blood pressure, high cholesterol and sleep apnea. For diabetes, approval does not depend on BMI.

The class is not for everyone. It is avoided with a personal or family history of medullary thyroid cancer, or the genetic condition MEN2. It is not used in pregnancy, and is approached carefully after pancreatitis or an eating disorder.

Someone chasing the last five pounds is a poor fit. Cost, gut effects and muscle loss all price that badly.

Side effects: what passes and what people stop for#

Almost everyone gets some gut effect, and most of it settles.

The ones that usually pass: nausea, burping, reflux, constipation, diarrhea, and feeling too full. These cluster in the first weeks and after each dose increase, then fade for most people. Smaller meals, less fried food and steady fluids help.

The ones people stop for: nausea that never lifts, repeated vomiting, constipation that no routine fixes, and food aversion strong enough to make eating miserable. In trials, roughly 4 to 7 percent of people left because of side effects.

The uncommon but serious ones: gallstones, which rise with any rapid weight loss. Pancreatitis, which is rare and causes severe upper stomach pain reaching through to the back. Bowel obstruction, which is rarer still. In diabetic eye disease, fast blood sugar improvement can briefly worsen the retina.

Dehydration is the quiet one. Less appetite means less drinking, which can affect the kidneys in older adults.

What happens when you stop#

This is the part that changes how the whole class should be understood.

In the withdrawal study, people who stopped semaglutide regained about two thirds of their lost weight within a year. Blood pressure and blood sugar drifted back too. Appetite returned first, and weight followed.

That is not a flaw in the drug or a failure of character. Blood pressure rises again when a blood pressure tablet stops. The biology was managed, not rewritten.

So this is best treated as a long term commitment, or as time bought to build habits that carry the result afterward. Ideally both.

The muscle question#

Fast weight loss always takes some muscle with it. Studies suggest roughly a quarter to 40 percent of the lost weight is lean tissue. That is what happens with any rapid loss, including surgery.

For a 35 year old with muscle to spare, that is a manageable trade. For a 70 year old, it is the difference between aging well and frailty.

Two things protect it, and both are free.

Protein at every meal. Our guides to protein targets and protein after 60 give the actual numbers. The challenge on a GLP-1 is fitting protein into a smaller appetite, so it goes first on the plate.

Resistance training two or three times a week. Bands, machines, body weight or free weights all count. Loading a muscle is the signal that tells the body to keep it.

Cost and access, honestly#

Price is the reason most people never start, and the reason many stop.

Coverage rules differ enormously from one plan to another. Diabetes use is covered far more often than weight use. Many plans require paperwork, a specific BMI, or a trial of other approaches first.

Paying out of pocket is expensive, and the expense repeats every month. Supply has been unreliable at times, and a gap restarts the side effects when you resume.

Compounded and online sources#

The price gap has created a market worth naming plainly. Compounded versions are mixed by pharmacies rather than made by the original manufacturer. They are not reviewed for strength or safety the way approved products are. Regulators have documented several problems.

  • Dosing errors from confusing units, where people drew up ten times the intended amount.
  • Salt forms of the drug that were never studied in people.
  • Products sold online with unreliable or absent active ingredient.

Some of these errors have led to hospital care for severe low blood sugar and dehydration. If a seller skips the prescription, skips your history, or hides its source, that is the whole answer.

What I get asked most#

The question I hear most is a version of "does taking this mean I failed?"

It does not. Body weight is defended by hormones that do not consult you. People who lose weight by effort alone are fighting a system built to restore it. That is why most diets return.

The second is about the face. People are told they look drawn. That is what fast weight loss looks like anywhere on the body. Slower loss, with protein and strength work, leaves a different result.

The third comes from families asking about a parent in their seventies. At that age the muscle question moves to the front of the line.

What to ask your doctor#

Take this list in with you.

  • Given my health history, what would this class change for me?
  • What is the target here: weight, blood sugar, heart risk, or several?
  • Which medicine fits my situation, and why that one?
  • What is the plan if the nausea does not settle?
  • How will we protect muscle and bone while I lose weight?
  • What is the plan if my coverage ends or supply runs out?
  • Do any of my current medicines need reviewing?

Bring your full medicine list, including supplements. Our guide to preparing for an appointment helps you get more out of a short visit.

What the evidence cannot tell us yet#

Honest gaps, stated plainly.

We do not have decades of data. The longest weight trials run a few years, so twenty year effects are unknown. We do not know the best way to stop, or whether a smaller maintenance approach holds the result. We do not know how much of the heart benefit comes from weight loss and how much from the drug.

Long term muscle and bone outcomes in older adults are not settled. Neither is the effect in people over 75, who were thinly represented. Reports of mood changes have been examined without a clear link, and monitoring continues.

When to see a doctor#

Get medical care the same day for:

  • Severe stomach pain that spreads to your back and will not ease.
  • Vomiting that stops you keeping fluids down.
  • Pain under the right ribs with fever, yellow eyes, or pale stools.
  • Signs of very low blood sugar: shaking, sweating, confusion, or feeling faint.
  • Any sudden change in vision.

Book a routine appointment if nausea or constipation is not settling. Do the same if you feel weak or unsteady, or if eating has become a problem.

The bottom line#

This drug class copies a gut hormone that slows the stomach and quiets appetite, and the results go far beyond anything before them. They also bring gut side effects, a muscle cost, an ongoing price, and weight regain after stopping. They treat a long term condition rather than curing it. Protein and strength work decide what your body is made of at the end, and both stay free.

Free. Instant. Sign in to save.Full calculator with waist ratio

Check your BMI now

Height and weight, metric.

Not magic, just convenient

Useful when your plan calls for more protein than your meals reach, especially for older adults protecting muscle. Whey or a plant blend both work; unflavored mixes into anything.

Buying through this link supports the free library with a small commission. It never changes a pick.

Have your own result?

Send the report. A doctor explains every value in writing within 3 days.

Common questions

How do GLP-1 drugs like Ozempic cause weight loss?
GLP-1 drugs copy a gut hormone that the body releases after eating. They slow how fast the stomach empties, so meals sit longer and fullness lasts. They also act on appetite centers in the brain, which quiets the constant pull toward food. Eating less stops feeling like a fight, and calorie intake falls without daily effort.
How much weight do people actually lose on these drugs?
In the largest trials, average loss was around 15 percent of body weight with semaglutide over 68 weeks. Tirzepatide averaged over 20 percent at the highest dose in its own trial. Averages hide a wide spread. Some people lose very little, and some lose more than a third of their weight. Nobody can predict which group you fall into.
What happens when you stop taking Ozempic?
Weight usually comes back after stopping, because appetite returns to where it was. In the withdrawal trials, people regained about two thirds of what they had lost within a year, and the blood pressure and blood sugar gains faded along with it. That is how a treatment for an ongoing condition behaves, not a sign of personal failure.
What are the side effects people actually stop for?
Most people stop because of gut side effects that never settle. Ongoing nausea, vomiting, constipation, and reflux are the usual reasons. In trials, roughly 4 to 7 percent of people quit for side effects. Rarer reasons include gallstones, pancreatitis, and a level of food aversion that makes eating unpleasant.
Do GLP-1 drugs cause muscle loss?
Yes, some of the weight lost is muscle, as it is with any fast weight loss. Body composition studies suggest roughly a quarter to 40 percent of the loss is lean tissue. That matters most after 60, when muscle protects against falls and frailty. Eating enough protein and doing strength work two or three times a week reduces the loss.
Who are these drugs approved for?
Regulators approve this drug class for type 2 diabetes. They approve it separately for weight management at a BMI of 30 or above. They are also approved at a BMI of 27 or above with a weight related condition. Examples include high blood pressure and sleep apnea. Some are approved to lower heart risk in specific groups.
Are compounded or online versions safe?
Compounded and unregulated online versions carry real risk and are not the same product. Regulators have reported overdoses from confusing units, wrong salt forms of the drug, and products with no reliable contents. Several people have needed hospital care after measuring errors. A lower price does not make a syringe safe.

People also ask

Not what you were looking for?

Say what you came for and we will take you there.

Sources

  1. FDA - Medications containing semaglutide
  2. NEJM - Once-weekly semaglutide in adults with overweight or obesity (STEP 1)
  3. NEJM - Semaglutide and cardiovascular outcomes in obesity (SELECT)
  4. NIDDK - Prescription medications to treat overweight and obesity
  5. FDA - Counterfeit medicine
  6. MedlinePlus: Obesity
Medically reviewed 6 September 2026How this was written and checked
A necessary note. This guide is health education. It cannot examine you, and it does not replace your own doctor's judgment about your case.